Extended Data Fig. 11: Selection of intrahepatic lymphoid aggregates in human liver tissue.
From: iHALT unlocks liver functionality as a surrogate secondary lymphoid organ
(A-F) For various labeled liver conditions, intrahepatic lymphoid aggregate selections utilized for downstream analysis (Fig. 5) were made based all of the following criteria being met: transcript density of LTB ≥ 4e−4, MS4A1 or CD4 ≥ 4e−3, CXCL13 ≥ 3e−4 or CCL19 ≥ 1e−3 and total transcript count of LTB ≥ 10, MS4A1 or CD4 ≥ 50.
